{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:30:47Z","timestamp":1792114247226,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Kr\u00fcppel-like Factor 4 (KLF4), a target gene of miR-145, can negatively regulate lung fibrosis. However, the potential role of KLF4 and miR-145 in hepatic stellate cells (HSCs) activation or in hepatic fibrosis keeps unclear. This study aims to characterize miR-145 and KLF4 in activated HSCs and liver cirrhotic, and the underlying molecular basis. miR-145 was significantly up-regulated, while KLF4 was dramatically down-regulated during the activation of rat primary HSCs and TGF-\u03b2treated HSCs. Furthermore, miR-145 mimics induced and inhibition of miR-145 reduced \u03b1-SMA and COL-I expression in primary HSCs. Additionally, the mRNA and protein levels of KLF4 in the liver of cirrhotic patients and rats were significantly down-regulated. \u03b1-SMA and COL-I were increased after inhibition of KLF4 by specific shRNA in primary HSCs. Forced KLF4 expression led to a reduction of \u03b1-SMA and COL-I expression in HSCs. miR-145 promotes HSC activation and liver fibrosis by targeting KLF4.<\/jats:p>","DOI":"10.1038\/srep40468","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T11:25:32Z","timestamp":1484565932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["MircoRNA-145 promotes activation of hepatic stellate cells via targeting kr\u00fcppel-like factor 4"],"prefix":"10.1038","volume":"7","author":[{"given":"Ruoting","family":"Men","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie Haitian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"key":"BFsrep40468_CR1","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1172\/JCI66369","volume":"123","author":"C Yin","year":"2013","unstructured":"Yin, C., Evason, K. J., Asahina, K. & Stainier, D. Y. Hepatic stellate cells in liver development, regeneration, and cancer. The Journal of clinical investigation 123, 1902\u20131910, doi: 10.1172\/JCI66369 (2013).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep40468_CR2","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan, D. & Kim, Y. O. Evolving therapies for liver fibrosis. The Journal of clinical investigation 123, 1887\u20131901, doi: 10.1172\/JCI66028 (2013).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep40468_CR3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jhep.2012.11.022","volume":"58","author":"C Roderburg","year":"2013","unstructured":"Roderburg, C. et al. miR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. Journal of hepatology 58, 736\u2013742, doi: 10.1016\/j.jhep.2012.11.022 (2013).","journal-title":"Journal of hepatology"},{"key":"BFsrep40468_CR4","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1016\/j.febslet.2013.09.047","volume":"587","author":"CJ Guo","year":"2013","unstructured":"Guo, C. J. et al. Dynamic expression of miR-126* and its effects on proliferation and contraction of hepatic stellate cells. FEBS letters 587, 3792\u20133801, doi: 10.1016\/j.febslet.2013.09.047 (2013).","journal-title":"FEBS letters"},{"key":"BFsrep40468_CR5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jhep.2012.11.011","volume":"58","author":"J Li","year":"2013","unstructured":"Li, J. et al. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. Journal of hepatology 58, 522\u2013528, doi: 10.1016\/j.jhep.2012.11.011 (2013).","journal-title":"Journal of hepatology"},{"key":"BFsrep40468_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bbrc.2009.11.056","volume":"391","author":"T Ogawa","year":"2010","unstructured":"Ogawa, T. et al. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochemical and biophysical research communications 391, 316\u2013321, doi: 10.1016\/j.bbrc.2009.11.056 (2010).","journal-title":"Biochemical and biophysical research communications"},{"key":"BFsrep40468_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1161\/CIRCGENETICS.110.958702","volume":"4","author":"AY Rangrez","year":"2011","unstructured":"Rangrez, A. Y., Massy, Z. A., Metzinger-Le Meuth, V. & Metzinger, L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circulation. Cardiovascular genetics 4, 197\u2013205, doi: 10.1161\/CIRCGENETICS.110.958702 (2011).","journal-title":"Circulation. Cardiovascular genetics"},{"key":"BFsrep40468_CR8","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1096\/fj.12-219493","volume":"27","author":"S Yang","year":"2013","unstructured":"Yang, S. et al. miR-145 regulates myofibroblast differentiation and lung fibrosis. The FASEB Journal 27, 2382\u20132391, doi: 10.1096\/fj.12-219493 (2013).","journal-title":"The FASEB Journal"},{"key":"BFsrep40468_CR9","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.4049\/jimmunol.1202960","volume":"190","author":"IK Oglesby","year":"2013","unstructured":"Oglesby, I. K., Chotirmall, S. H., McElvaney, N. G. & Greene, C. M. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in DeltaF508 cystic fibrosis airway epithelium. J Immunol 190, 3354\u20133362, doi: 10.4049\/jimmunol.1202960 (2013).","journal-title":"J Immunol"},{"key":"BFsrep40468_CR10","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.3748\/wjg.v19.i43.7758","volume":"19","author":"X-L Wu","year":"2013","unstructured":"Wu, X.-L. MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2. World Journal of Gastroenterology 19, 7758, doi: 10.3748\/wjg.v19.i43.7758 (2013).","journal-title":"World Journal of Gastroenterology"},{"key":"BFsrep40468_CR11","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1111\/j.1742-4658.2009.07213.x","volume":"276","author":"CJ Guo","year":"2009","unstructured":"Guo, C. J. et al. Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways. FEBS journal 276, 5163\u20135176 (2009).","journal-title":"FEBS journal"},{"key":"BFsrep40468_CR12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.2174\/15680096113136660104","volume":"13","author":"J Cui","year":"2013","unstructured":"Cui, J., Shi, M., Quan, M. & Xie, K. Regulation of EMT by KLF4 in Gastrointestinal Cancer. Current cancer drug targets 13, 986\u2013995 (2013).","journal-title":"Current cancer drug targets"},{"key":"BFsrep40468_CR13","doi-asserted-by":"publisher","first-page":"e43593","DOI":"10.1371\/journal.pone.0043593","volume":"7","author":"C-M Wong","year":"2012","unstructured":"Wong, C.-M. et al. Kr\u00fcppel-Like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug Expression. PLoS One 7, e43593, doi: 10.1371\/journal.pone.0043593 (2012).","journal-title":"PLoS One"},{"key":"BFsrep40468_CR14","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","volume":"64","author":"G Marrone","year":"2015","unstructured":"Marrone, G. et al. KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins. Gut 64, 1434\u20131443 (2015).","journal-title":"Gut"},{"key":"BFsrep40468_CR15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.bbrc.2009.12.002","volume":"391","author":"G Villarreal Jr.","year":"2010","unstructured":"Villarreal, G. Jr. et al. Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells. Biochemical and biophysical research communications 391, 984\u2013989, doi: 10.1016\/j.bbrc.2009.12.002 (2010).","journal-title":"Biochemical and biophysical research communications"},{"key":"BFsrep40468_CR16","doi-asserted-by":"publisher","first-page":"e63424","DOI":"10.1371\/journal.pone.0063424","volume":"8","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Kr\u00fcppel-Like Factor 4 Transcriptionally Regulates TGF-\u03b21 and Contributes to Cardiac Myofibroblast Differentiation. PLoS One 8, e63424 (2013).","journal-title":"PLoS One"},{"key":"BFsrep40468_CR17","doi-asserted-by":"publisher","first-page":"28097","DOI":"10.1074\/jbc.M111.236950","volume":"286","author":"BN Davis-Dusenbery","year":"2011","unstructured":"Davis-Dusenbery, B. N. et al. down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143\/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. The Journal of biological chemistry 286, 28097\u201328110, doi: 10.1074\/jbc.M111.236950 (2011).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep40468_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.lfs.2016.04.034","volume":"155","author":"M Wen","year":"2016","unstructured":"Wen, M., Men, R., Liu, X. & Yang, L. Involvement of miR-30c in hepatic stellate cell activation through the repression of plasminogen activator inhibitor-1. Life sciences 155, 21\u201328 (2016).","journal-title":"Life sciences"},{"key":"BFsrep40468_CR19","doi-asserted-by":"publisher","first-page":"G262","DOI":"10.1152\/ajpgi.00257.2015","volume":"310","author":"Y Li","year":"2016","unstructured":"Li, Y., Lua, I., French, S. W. & Asahina, K. Role of TGF-beta signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis. American journal of physiology. Gastrointestinal and liver physiology 310, G262\u2013272, doi: 10.1152\/ajpgi.00257.2015 (2016).","journal-title":"American journal of physiology. Gastrointestinal and liver physiology"},{"key":"BFsrep40468_CR20","first-page":"107","volume":"62","author":"P He","year":"2016","unstructured":"He, P., Yu, Z. J., Sun, C. Y., Jiao, S. J. & Jiang, H. Q. Knockdown of eIF3a attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-beta1. Cell Mol Biol (Noisy-le-grand) 62, 107\u2013111 (2016).","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"BFsrep40468_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fphys.2012.00053","volume":"3","author":"K Yoshida","year":"2012","unstructured":"Yoshida, K. & Matsuzaki, K. Differential Regulation of TGF-beta\/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries. Frontiers in physiology 3, 53, doi: 10.3389\/fphys.2012.00053 (2012).","journal-title":"Frontiers in physiology"},{"key":"BFsrep40468_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature08195","volume":"460","author":"KR Cordes","year":"2009","unstructured":"Cordes, K. R. et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705\u2013710, doi: 10.1038\/nature08195 (2009).","journal-title":"Nature"},{"key":"BFsrep40468_CR23","doi-asserted-by":"publisher","first-page":"9261","DOI":"10.1074\/jbc.M112.433730","volume":"288","author":"H Liu","year":"2013","unstructured":"Liu, H. et al. miR-145 and miR-143 regulate odontoblast differentiation through targeting Klf4 and Osx genes in a feedback loop. The Journal of biological chemistry 288, 9261\u20139271, doi: 10.1074\/jbc.M112.433730 (2013).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep40468_CR24","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.cellsig.2012.07.023","volume":"24","author":"Y He","year":"2012","unstructured":"He, Y. et al. The potential of microRNAs in liver fibrosis. Cellular signalling 24, 2268\u20132272, doi: 10.1016\/j.cellsig.2012.07.023 (2012).","journal-title":"Cellular signalling"},{"key":"BFsrep40468_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.23922","volume":"53","author":"C Roderburg","year":"2011","unstructured":"Roderburg, C. et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209\u2013218, doi: 10.1002\/hep.23922 (2011).","journal-title":"Hepatology"},{"key":"BFsrep40468_CR26","doi-asserted-by":"publisher","first-page":"e108005","DOI":"10.1371\/journal.pone.0108005","volume":"9","author":"J Zhao","year":"2014","unstructured":"Zhao, J. et al. MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis. PLoS One 9, e108005, doi: 10.1371\/journal.pone.0108005 (2014).","journal-title":"PLoS One"},{"key":"BFsrep40468_CR27","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","volume":"50","author":"CJ Guo","year":"2009","unstructured":"Guo, C. J., Pan, Q., Li, D. G., Sun, H. & Liu, B. W. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. Journal of hepatology 50, 766\u2013778, doi: 10.1016\/j.jhep.2008.11.025 (2009).","journal-title":"Journal of hepatology"},{"key":"BFsrep40468_CR28","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway. Oncotarget (2014).","DOI":"10.18632\/oncotarget.2621"},{"key":"BFsrep40468_CR29","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1096\/fj.12-219493","volume":"27","author":"S Yang","year":"2013","unstructured":"Yang, S. et al. miR-145 regulates myofibroblast differentiation and lung fibrosis. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 27, 2382\u20132391, doi: 10.1096\/fj.12-219493 (2013).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"BFsrep40468_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/cas.12329","volume":"105","author":"Y Naito","year":"2014","unstructured":"Naito, Y. et al. MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer science 105, 228\u2013235, doi: 10.1111\/cas.12329 (2014).","journal-title":"Cancer science"},{"key":"BFsrep40468_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.molimm.2016.05.018","volume":"75","author":"DD Zhou","year":"2016","unstructured":"Zhou, D. D. et al. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt\/beta-catenin pathway. Molecular immunology 75, 151\u2013160, doi: 10.1016\/j.molimm.2016.05.018 (2016).","journal-title":"Molecular immunology"},{"key":"BFsrep40468_CR32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/hep.25613","volume":"56","author":"AM Lakner","year":"2012","unstructured":"Lakner, A. M. et al. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology 56, 300\u2013310, doi: 10.1002\/hep.25613 (2012).","journal-title":"Hepatology"},{"key":"BFsrep40468_CR33","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.cellsig.2012.06.003","volume":"24","author":"Y He","year":"2012","unstructured":"He, Y. et al. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cellular signalling 24, 1923\u20131930, doi: 10.1016\/j.cellsig.2012.06.003 (2012).","journal-title":"Cellular signalling"},{"key":"BFsrep40468_CR34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0168-8278(03)00360-X","volume":"39","author":"P St\u00e4rkel","year":"2003","unstructured":"St\u00e4rkel, P. et al. Oxidative stress, KLF6 and transforming growth factor-\u03b2 up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. Journal of hepatology 39, 538\u2013546 (2003).","journal-title":"Journal of hepatology"},{"key":"BFsrep40468_CR35","doi-asserted-by":"crossref","unstructured":"Men, R. et al. Nogo-B: A potential indicator for hepatic cirrhosis and regulator in hepatic stellate cell activation. Hepatology research: the official journal of the Japan Society of Hepatology, doi: 10.1111\/hepr.12324 (2014).","DOI":"10.1111\/hepr.12324"},{"key":"BFsrep40468_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/hepr.12324","volume":"45","author":"R Men","year":"2015","unstructured":"Men, R. et al. Nogo-B: A potential indicator for hepatic cirrhosis and regulator in hepatic stellate cell activation. Hepatology Research 45, 113\u2013122 (2015).","journal-title":"Hepatology Research"},{"key":"BFsrep40468_CR37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jep.2014.10.028","volume":"158","author":"Y Jiang","year":"2014","unstructured":"Jiang, Y. et al. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-beta\/Smad interference. Journal of ethnopharmacology 158 Pt A, 230\u2013238, doi: 10.1016\/j.jep.2014.10.028 (2014).","journal-title":"Journal of ethnopharmacology"}],"updated-by":[{"DOI":"10.1038\/s41598-023-36674-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep40468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep40468","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep40468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T12:12:05Z","timestamp":1686658325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep40468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,7]]}},"alternative-id":["BFsrep40468"],"URL":"https:\/\/doi.org\/10.1038\/srep40468","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-023-36674-4","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]},"assertion":[{"value":"4 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-36674-4","URL":"https:\/\/doi.org\/10.1038\/s41598-023-36674-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40468"}}